Reference SummaryBaldrick P, Toxicol Pathol 2007;35(4):562-9
Title |
Carcinogenicity evaluation: comparison of tumor data from dual control groups in the CD-1 mouse. | ||||
Authors |
Baldrick P; Reeve L | ||||
Journal |
Toxicol Pathol | ||||
Volume |
35 | ||||
Issue |
4 | ||||
Year |
2007 | ||||
Pages |
562-9 | ||||
Abstract |
Current regulatory thinking allows for the use of single control groups for rodent carcinogenicity testing although there has been a trend until recently to use dual control groups. To date, virtually nothing has been published on whether a shift from dual to single control groups will affect the identification of tumorigenic risk potential in these studies. A recent evaluation of dual control carcinogenicity data in the rat (Baldrick, Toxicol Pathol 2005, 33: 283-291) showed that although no major differences in tumor incidences between the control groups were found, some interstudy variation occurred and in cases were a notable difference was seen, the use of 2 control groups, as well as robust, contemporary background data, allowed an easier interpretation of findings in drug-treated groups. In this paper, the results of 10 mouse carcinogenicity studies, performed between 1991 and 2004, with 2 control groups, are presented. As in the rat, interstudy variation was seen and in some cases, the use of dual control groups assisted in the tumor risk assessment. Thus, the continued use of 2 control groups can have a vital role in mouse carcinogenicity studies. The paper also presents an update on survival, on the range and extent of background spontaneous neoplasms and comments on genetic drift in this commonly used mouse strain. | ||||
Links |
J:134840 – MGI References 17562489 – National Library of Medicine/PubMed |
||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
CD-1 | Abdominal cavity tumor - histiocytic | Abdominal cavity |
10 - 12.5 |
||
CD-1 | Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
0.4 - 0.8 |
||
CD-1 | Adrenal gland - Medulla pheochromocytoma - benign | Adrenal gland - Medulla |
0.3 - 1.1 |
||
CD-1 | Adrenal gland - Subcapsular cell adenoma | Adrenal gland - Subcapsular cell |
0.2 - 8.6 |
||
CD-1 | Adrenal gland - Subcapsular cell hyperplasia | Adrenal gland - Subcapsular cell |
observed |
||
CD-1 | Adrenal gland adenoma | Adrenal gland |
2.0 |
||
CD-1 | Blood vessel hemangioma | Liver |
0 - 5.0 |
||
CD-1 | Blood vessel hemangioma | Spleen |
0.4 - 2.0 |
||
CD-1 | Blood vessel hemangioma | Uterus |
1.3 - 3.9 |
||
CD-1 | Blood vessel hemangioma | Skin |
0.4 |
||
CD-1 | Blood vessel hemangioma | Testis |
0.6 |
||
CD-1 | Blood vessel hemangioma | Lymph node - Mesenteric |
1.1 |
||
CD-1 | Blood vessel hemangioma | Bone - Femur |
0.5 |
||
CD-1 | Blood vessel hemangioma | Bone - Sternum |
0.8 |
||
CD-1 | Blood vessel hemangioma | Tail |
1.3 |
||
CD-1 | Blood vessel hemangioma | Leg |
14 |
||
CD-1 | Blood vessel hemangioma | Stomach |
1.5 |
||
CD-1 | Blood vessel hemangioma | (Unspecified organ) |
3.3 - 6.7 |
||
CD-1 | Blood vessel hemangioma | Thymus |
1.9 |
||
CD-1 | Blood vessel hemangioma | Abdominal cavity |
20 |
||
CD-1 | Blood vessel hemangiosarcoma | Skin |
0.3 - 0.6 |
||
CD-1 | Blood vessel hemangiosarcoma | Spleen |
0.6 |
||
CD-1 | Blood vessel hemangiosarcoma | (Unspecified organ) |
1.6 - 3.2 |
||
CD-1 | Blood vessel hemangiosarcoma | Liver |
0.4 - 0.7 |
||
CD-1 | Blood vessel hemangiosarcoma | Intestine - Large Intestine - Colon |
2.0 |
||
CD-1 | Blood vessel hemangiosarcoma | Bone |
5.0 |
||
CD-1 | Blood vessel hemangiosarcoma | Muscle |
0.9 |
||
CD-1 | Blood vessel hemangiosarcoma | Thoracic cavity |
12.5 |
||
CD-1 | Blood vessel hemangiosarcoma | Uterus |
0.4 |
||
CD-1 | Blood vessel hemangiosarcoma | Blood vessel |
0 - 5.0 |
||
CD-1 | Bone marrow hyperplasia | Bone marrow |
observed |
||
CD-1 | Bone osteoma | Bone - Femur |
0.3 - 0.7 |
||
CD-1 | Bone osteoma | Bone |
11 - 33 |
||
CD-1 | Bone osteosarcoma | Skin |
0.2 - 0.5 |
||
CD-1 | Bone osteosarcoma | Stomach |
0.9 |
||
CD-1 | Bone osteosarcoma | Bone |
10 - 67 |
||
CD-1 | Bone osteosarcoma | Uterus |
1.7 |
||
CD-1 | Connective tissue - Fibroblast fibrosarcoma | Skin |
0 - 8.3 |
||
CD-1 | Ear - Zymbal gland carcinoma | Ear - Zymbal gland |
1.7 |
||
CD-1 | Ear - Zymbal gland carcinoma - sebaceous | Ear - Zymbal gland |
1.7 |
||
CD-1 | Eye - Harderian gland adenocarcinoma | Eye - Harderian gland |
0.8 - 2.4 |
||
CD-1 | Eye - Harderian gland adenoma | Eye - Harderian gland |
7.4 - 19.4 |
||
CD-1 | Gallbladder papilloma | Gallbladder |
0.5 - 1.1 |
||
CD-1 | Intestine - Large Intestine - Cecum carcinoma | Intestine - Large Intestine - Cecum |
1.0 |
||
CD-1 | Intestine - Small Intestine - Duodenum adenoma | Intestine - Small Intestine - Duodenum |
0.4 |
||
CD-1 | Intestine - Small Intestine - Duodenum hyperplasia - avillous | Intestine - Small Intestine - Duodenum |
observed |
||
CD-1 | Intestine - Small Intestine - Jejunum adenoma | Intestine - Small Intestine - Jejunum |
2.1 |
||
CD-1 | Kidney - Renal tubule adenoma | Kidney - Renal tubule |
0 - 0.5 |
||
CD-1 | Kidney - Renal tubule carcinoma | Kidney - Renal tubule |
0 - 5.9 |
||
CD-1 | Kidney cyst | Kidney |
observed |
||
CD-1 | Leg squamous cell papilloma | Leg |
50 |
||
CD-1 | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell lymphoma - plasmacytic | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
0.7 |
||
CD-1 | Leukocyte - Lymphocyte hyperplasia | Lymph node - Mandibular |
observed |
||
CD-1 | Leukocyte - Lymphocyte hyperplasia | Lymph node - Mesenteric |
observed |
||
CD-1 | Leukocyte - Lymphocyte hyperplasia | Spleen |
observed |
||
CD-1 | Leukocyte - Lymphocyte hyperplasia | Thymus |
observed |
||
CD-1 | Leukocyte - Lymphocyte leukemia - lymphocytic | Spleen |
3.1 - 5.1 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Liver |
0 - 0.7 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
0 - 6.7 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Uterus |
0 - 12.5 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Skin |
0.4 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Epididymis |
2.0 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Uterus - Cervix |
1.7 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Connective tissue |
20 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Vagina |
1.7 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Lymph node - Mesenteric |
2.0 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Skin |
1.1 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Preputial gland (male) |
3.1 - 5.9 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Epididymis |
0.6 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Ear |
12.5 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Clitoral gland |
1.7 |
||
CD-1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma - benign | Vagina |
1.6 |
||
CD-1 | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell tumor | Leukocyte - Myelocyte (Granulocyte) - Basophil - Mast cell |
0.8 - 1.0 |
||
CD-1 | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
1.4 - 4.8 |
||
CD-1 | Leukocyte leukemia - unclassified | Leukocyte |
0.3 - 0.8 |
||
CD-1 | Leukocyte leukemia - undifferentiated | Leukocyte |
20 |
||
CD-1 | Leukocyte lymphoma - lymphoblastic | Leukocyte |
1.4 - 6.8 |
||
CD-1 | Leukocyte lymphoma - lymphocytic | Leukocyte |
1.7 - 9.8 |
||
CD-1 | Leukocyte lymphoma - pleomorphic | Leukocyte |
7.9 - 23.3 |
||
CD-1 | Leukocyte lymphoma - unclassified | Leukocyte |
3.6 - 18.6 |
||
CD-1 | Liver carcinoma - histiocytic | Liver |
2.0 |
||
CD-1 | Liver hepatocellular adenoma | Liver |
0 - 28.3 |
||
CD-1 | Liver hepatocellular carcinoma | Liver |
0 - 3.2 |
||
CD-1 | Lung adenoma | Lung |
3.3 - 23.5 |
||
CD-1 | Lung carcinoma | Lung |
1.7 - 13.2 |
||
CD-1 | Mammary gland adenocarcinoma | Mammary gland |
0 - 4.7 |
||
CD-1 | Mammary gland adenoma | Mammary gland |
1.2 |
||
CD-1 | Mammary gland carcinosarcoma | Mammary gland |
0.8 - 4.0 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Skin |
0 - 6.7 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Uterus - Endometrium - Stroma |
1.0 - 1.6 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Abdominal cavity |
10.5 - 17 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Ear |
25 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Vagina |
1.7 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Kidney |
0.9 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Thoracic cavity |
4.2 - 7.7 |
||
CD-1 | Mesodermal cell/mesoblast sarcoma | Uterus |
1.7 |
||
CD-1 | Muscle - Smooth leiomyoma | Uterus |
3.3 - 9.8 |
||
CD-1 | Muscle - Smooth leiomyoma | Stomach |
2.0 |
||
CD-1 | Muscle - Smooth leiomyoma | Ovary |
0.6 |
||
CD-1 | Muscle - Smooth leiomyoma | Uterus - Cervix |
1.7 |
||
CD-1 | Muscle - Smooth leiomyosarcoma | Uterus |
0.5 - 0.9 |
||
CD-1 | Muscle - Smooth leiomyosarcoma | Esophagus |
2.0 |
||
CD-1 | Muscle - Striated - Skeletal rhabdomyosarcoma | Skin |
1.5 |
||
CD-1 | Oral cavity squamous cell papilloma | Oral cavity |
100 |
||
CD-1 | Ovary - Granulosa cell tumor - benign | Ovary - Granulosa cell |
0.9 - 1.1 |
||
CD-1 | Ovary - Sertoli cell tumor - benign | Ovary - Sertoli cell |
1.6 |
||
CD-1 | Ovary - Sex cord stromal cell tumor - benign | Ovary - Sex cord stromal cell |
0.6 |
||
CD-1 | Ovary adenoma - tubulostromal | Ovary |
0.6 - 1.2 |
||
CD-1 | Ovary cyst | Ovary |
observed |
||
CD-1 | Ovary cystadenoma | Ovary |
0.7 - 0.9 |
||
CD-1 | Ovary luteoma | Ovary |
0.7 - 1.4 |
||
CD-1 | Pancreas - Islet of Langerhans adenoma | Pancreas - Islet of Langerhans |
0 - 7.8 |
||
CD-1 | Parathyroid gland adenoma | Parathyroid gland |
0.6 |
||
CD-1 | Pituitary gland adenoma | Pituitary gland |
0 - 6.8 |
||
CD-1 | Pituitary gland carcinoma | Pituitary gland |
1.6 |
||
CD-1 | Salivary gland adenocarcinoma | Salivary gland |
1.6 |
||
CD-1 | Salivary gland carcinoma | Salivary gland |
1.7 |
||
CD-1 | Skin - Epidermis - Basal cell tumor - malignant | Skin - Epidermis - Basal cell |
0.6 |
||
CD-1 | Skin - Hair follicle - Basal cell trichoepithelioma | Skin - Hair follicle - Basal cell |
2.0 |
||
CD-1 | Skin - Hair follicle tumor | Skin - Hair follicle |
0.9 |
||
CD-1 | Skin - Melanocyte melanoma - benign | Skin - Melanocyte |
1.7 |
||
CD-1 | Skin adenoma - sebaceous | Skin |
0.9 - 1.8 |
||
CD-1 | Skin keratoacanthoma | Skin |
2.0 |
||
CD-1 | Skin squamous cell carcinoma | Skin |
0.3 - 0.7 |
||
CD-1 | Skin squamous cell papilloma | Skin |
0.2 - 0.4 |
||
CD-1 | Stomach adenoma | Stomach |
1.0 |
||
CD-1 | Stomach squamous cell papilloma | Stomach |
0.3 - 0.6 |
||
CD-1 | Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
observed |
||
CD-1 | Testis - Leydig cell (Interstitial cell) tumor - benign | Testis - Leydig cell (Interstitial cell) |
1.5 - 1.9 |
||
CD-1 | Testis - Rete testis adenoma | Testis - Rete testis |
1.7 |
||
CD-1 | Thymus cyst | Thymus |
observed |
||
CD-1 | Thymus thymoma | Thymus |
0.6 - 0.7 |
||
CD-1 | Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
0.3 - 0.7 |
||
CD-1 | Thyroid gland - Follicular cell cyst | Thyroid gland - Follicular cell |
observed |
||
CD-1 | Tongue squamous cell papilloma | Tongue |
0.8 - 1.5 |
||
CD-1 | Tooth tumor - benign | Oral cavity |
100 |
||
CD-1 | Uterus - Cervix - Stroma polyp | Uterus - Cervix - Stroma |
1.7 |
||
CD-1 | Uterus - Endometrium - Stroma polyp | Uterus - Endometrium - Stroma |
0 - 17.6 |
||
CD-1 | Uterus - Endometrium hyperplasia | Uterus - Endometrium |
observed |
||
CD-1 | Uterus adenoma | Uterus |
0.6 |
||
CD-1 | Uterus metaplasia - squamous | Uterus |
observed |
||
CD-1 | Uterus tumor - granular cell - benign | Uterus |
0.8 |
||
CD-1 | Vagina squamous cell hyperplasia | Vagina |
observed |
||
CD-1 | (Unspecified organ) histiocytoma - fibrous - malignant | Skin |
0 - 10.9 |
||
CD-1 | (Unspecified organ) neoplasm | (Unspecified organ) |
79 - 86 |
||
CD-1 | (Unspecified organ) neoplasm - benign | (Unspecified organ) |
37 - 56 |
||
CD-1 | (Unspecified organ) neoplasm - malignant | (Unspecified organ) |
24 - 49 |